abstract |
There are provided compounds of formula (I), wherein R1, R6 R8 Q2 Q3 Q3a Q4, L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer. |